In every corner of the world, the act of blood transfusion represents a profound covenant of trust between parties; first, ...
Nagpur, achieved a major healthcare milestone with the inauguration of three key patient care facilities — the assisted ...
HepQuant, a leader in developing noninvasive, blood-based, quantitative testing to assess liver health, will present three exciting abstracts demonstrating HepQuant DuO utility at The Liver Meeting ...
Nagpur marked a major milestone in healthcare advancement with the inauguration of its patient care facilities and services, ...
UCF scientists develop low-cost test to detect hepatitis B, hepatitis C and HIV viruses at same time
A multidisciplinary research team at the University of Central Florida has received US $537,619 from the National Institutes ...
SHELTON, CONNECTICUT / ACCESS Newswire / November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...
Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.
HCVcAg testing was effective in accurately identifying acute or recent HCV infection in patients with HIV infection.
From 2014 to 2021, approximately only one-third of US adults diagnosed with hepatitis C received treatment, despite curative therapies.
Rapid expansion of the global market due to increasing awareness, digital health innovations, and early detection programsAustin, Nov. 12, 2025 (GLOBE NEWSWIRE) -- STD Diagnostics Market Size and ...
HealthDay News — Multicancer early detection (MCED) tests can increase earlier-stage diagnoses and reduce late-stage diagnoses, according to a study published in Cancer.
New clinical research has identified a blood test that can reveal which women are more likely to respond to a particular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback